OTRK.NASDAQOntrak, INC

8-K: Ontrak Faces Nasdaq Delisting, Ceases Operations

Sentiment:

Delisting Notice


Ontrak, Inc. received a delisting notice from Nasdaq due to failing the minimum bid price rule and being deemed a public shell, following its decision to cease operations.

Worse than expectedThe company failed to meet Nasdaq's minimum bid price requirement.Nasdaq determined the company is a 'public shell' and its continued listing is unwarranted.The company has ceased all operations and terminated all employees.The company will be delisted from Nasdaq without appeal.

Summary

  • Ontrak, Inc. received a letter from The Nasdaq Stock Market, LLC on August 7, 2025, stating it no longer meets the minimum bid price requirement of $1.00.
  • The company's common stock closing bid price was less than $1.00 from June 25 through August 6, 2025.
  • Due to a Nasdaq Discretionary Panel Monitor in effect since October 7, 2024, the company is not eligible for a grace period to regain compliance.
  • Nasdaq Staff also determined the company is a 'public shell' under Nasdaq Listing Rule 5101, deeming continued listing unwarranted.
  • The company's board of directors previously determined to cease all operations and terminate all employees effective July 31, 2025.
  • Ontrak does not plan to appeal the delisting determination.
  • Trading of the company's common stock on Nasdaq is expected to be suspended at the opening of business on August 18, 2025.
  • Following suspension, the common stock may be quoted on the OTC Markets Group.

Sentiment

Score: 1

Explanation: The filing indicates a complete failure of the company, with cessation of operations, termination of all employees, and imminent delisting from Nasdaq, signifying a near-total loss of value for shareholders.

Negatives

  • Failure to meet Nasdaq's minimum bid price requirement of $1.00.
  • Ineligibility for a grace period due to an existing Nasdaq Discretionary Panel Monitor.
  • Determination by Nasdaq Staff that the company is a 'public shell'.
  • Decision by the board of directors to cease all company operations.
  • Termination of all company employees effective July 31, 2025.
  • Imminent delisting from The Nasdaq Capital Market.
  • Lack of plans to appeal the delisting decision.

Risks

  • Loss of liquidity and market access due to delisting from Nasdaq.
  • Potential for further decline in stock value and difficulty in trading on OTC Markets Group.
  • Complete cessation of business operations, indicating no future revenue or growth prospects.
  • The company being deemed a 'public shell' by Nasdaq, which can deter investors.

Future Outlook

The company's common stock is expected to be suspended from trading on Nasdaq on August 18, 2025, with no appeal planned. Following delisting, the stock may be quoted on the OTC Markets Group. The company has ceased all operations.

Management Comments

  • "The Company does not plan to request an appeal of the delisting determination and expects that trading of the Company's common stock on Nasdaq will be suspended at the opening of business on August 18, 2025."

Industry Context

This announcement reflects a company-specific failure rather than a broader industry trend. The cessation of operations and delisting indicate a complete breakdown of the company's business model and financial viability, independent of general market conditions or competitive pressures within its former sector.

Stakeholder Impact

  • Shareholders face significant negative impact due to the delisting, loss of liquidity, and the company ceasing all operations, likely resulting in substantial or complete loss of investment value.
  • All employees were terminated effective July 31, 2025, indicating a complete cessation of employment for the company's workforce.

Next Steps

  • Trading of common stock will be suspended on The Nasdaq Capital Market at the opening of business on August 18, 2025.
  • A Form 25-NSE will be filed with the SEC to remove the company's securities from listing and registration on Nasdaq.
  • The company's common stock may be quoted on the OTC Markets Group following Nasdaq suspension.

Key Dates

DateDescription
October 7, 2024Start of the one-year Nasdaq Discretionary Panel Monitor period.
June 25, 2025Beginning of the period during which the common stock's closing bid price was less than $1.00.
July 31, 2025Board of directors determined to cease company operations and terminate all employees.
August 6, 2025End of the period during which the common stock's closing bid price was less than $1.00.
August 7, 2025Received a letter from The Nasdaq Stock Market, LLC regarding delisting.
August 14, 2025Deadline to request an appeal of the delisting determination.
August 18, 2025Expected suspension of trading of the common stock on The Nasdaq Capital Market.

Recommendation

strong sell

The company has ceased all operations, terminated all employees, and is being delisted from Nasdaq, indicating a complete business failure. The stock is likely to become illiquid and worthless, warranting an immediate exit for any remaining shareholders.

Keywords

Ontrak, OTRK, Nasdaq, delisting, public shell, minimum bid price, operations ceased, stock market, OTC Markets, 8-K filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.